A 60-something woman with skin so itchy it caused her to scratch until she created lesions finally found relief from using cannabis.
Articles
The Mental Health Crisis: A Pandemic Becomes A Catastrophe
Two pandemics are currently afflicting the planet. While our governments focus on the smaller one (COVID-19), the larger one (the Mental Health Crisis) is rapidly spiralling out of control.
Peter Thiel-Backed Psychedelics Firm Buys Majority of Brain-Control Interface Firm
ATAI Life Sciences, a biosciences company backed by venture capitalist and freedom-loving billionaire Peter Thiel that specializes in experimental treatment of mental disorders with psychedelic drugs, has bought out a majority stake in a company working to meld the mind with machines.
MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors
MINDCURE increases its strategic investment in ATMA Journey Centers and deploys its iSTRYM digital therapeutics platform.
Texas Lawmakers Unanimously Approve Medical Marijuana Expansion Bill In Committee
A Texas House committee on Wednesday approved a bill to significantly expand the state’s medical marijuana program.
atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders
atai acquires a majority stake in Delaware-based Psyber, Inc., which has a strong focus on digital therapeutics.
Psychedelic Stocks Primed For atai-MindMed Bounce
Both the atai Life Sciences IPO and a MindMed uplisting to the NASDAQ are highly anticipated events. They could occur within weeks -- or even days -- of each other.
Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical
Mydecine announces several steps in its drug R&D, including four new novel drug candidates.
California Senators Approve Bill To Legalize Possession Of Psychedelics Like LSD, MDMA And Psilocybin
A bill to decriminalize psychedelics in California and create a working group to study broader reform advanced through a Senate committee on Tuesday.
Hard Numbers On The Huge Potential Of Psychedelic Drug Development
Drug development is expensive. It is also EXTREMELY lucrative. We take a close look at this revenue potential.
Illinois Smashes Marijuana Sales Record, Exceeding $100 Million In March
Monthly marijuana sales exceeded $100 million for the first time in Illinois in March, shattering the previous record.
Third Massachusetts City Approves Psychedelics Decriminalization Measure
Another Massachusetts city has approved a measure to deprioritize enforcement of laws against the possession, use and distribution of a wide range of psychedelics such as psilocybin and ayahuasca.
Bipartisan State Attorneys General Urge Congress To Pass Marijuana Banking Bill
Three state attorneys general and the top prosecutor for Washington, D.C. sent a letter to congressional leaders on Thursday, reiterating their support for legislation that would protect banks that service state-legal marijuana markets from being penalized by federal regulators.
Colorado Is Auctioning Marijuana-Themed License Plates To Raise Money For People With Disabilities
Colorado is really leaning into its reputation as the marijuana state—for a good cause.
Microdosing psychedelic drugs associated with increases in conscientiousness and reductions in neuroticism
Microdosing has become something of a wellness trend in recent years, gathering traction in Australia and overseas.